Navigation Links
DePuy ASR Lawsuit Update: Rottenstein Law Group Comments on Delay of Second Federal Trial
Date:5/8/2013

(PRWEB) May 08, 2013

A federal judge recently issued an order postponing the second federal DePuy ASR bellwether trial from July to September, according to court documents. The Rottenstein Law Group, which offers information about the ASR hip implant and provides news updates on the product at http://www.depuyrecallnewscenter.com/lawsuits, offers insight into what this means for those looking to file DePuy lawsuits.

Judge David Katz issued the order on April 22, three days after the first ASR bellwether trial was pushed back from May to June, according to court documents in MDL-2197, U.S. District Court for the Northern District of Ohio.

“Delays can happen,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “This does not mean that those who seek to file hip implant lawsuits should be concerned about retaining an attorney for alleged harms such as metal poisoning, pain and discomfort. Every victim can have his or her day in court if he or she wants it."

There are an additional 11,000 lawsuits pending against DePuy over the ASR across the nation in state and federal courts, according to Bloomberg.* DePuy voluntarily recalled the ASR in August 2010. The first hip trial in Los Angeles resulted in the plaintiff winning an $8.3 million damages award (Kransky v. DePuy; BC456086, Los Angeles Superior Court).

The Rottenstein Law Group encourages hip implant recipients to visit http://www.depuyrecallnewscenter.com/lawsuit/ to learn more about DePuy ASR lawsuits and to speak with a DePuy hip lawyer.

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group’s Injury Lawyer Newswire at http://www.injurylawyernewswire.com. Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.

*bloomberg.com/news/2013-04-15/j-j-jury-should-award-5-million-for-defective-hip-lawyer-says.html

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

###

Read the full story at http://www.prweb.com/releases/depuy-hip-replacement/depuy-recall/prweb10714338.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Rescheduling of First Bellwether Trial in Federal DePuy ASR Litigation
2. Alleged DePuy Knee Sleeve Failure Lawsuits Now Being Reviewed by Resource4thePeople Attorneys
3. DePuy ASR Lawsuit Update: Rottenstein Law Group Addresses J&J Motion to Appeal $8.3 Million Verdict
4. DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
5. California Jury Awards Man $8 Million after Injured by Defective DePuy ASR Hip Implant
6. DrugRisk Announces Launch of DePuy Hip Resource Center
7. Ongoing Litigation Over Failed DePuy and Stryker Hip Implants Continue Driving Traffic to Number One Website for Cobalt Chromium Toxicity Information
8. Compensation Justified in DePuy ASR $8.35 Million Verdict
9. Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
10. DePuy ASR Hip Replacement Lawsuit Lawyers at Wright & Schulte LLC Report Latest Developments in DePuy ASR Hip Implant Recall Lawsuits
11. US Drug Watchdog Is Now Urging Recipients Of A Recalled DePuy ASR Metal on Metal Hip Implant To Call Them If They Do Not Have A Law Firm-Before Time Could Run Out
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology: